Eurelix 0.25mg Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Eurelix 0.25mg Injection
Ganirelix 0.25mg Injection is a GnRH antagonist indicated for managing female infertility. It inhibits premature egg release, preventing ovulation. Administration is via subcutaneous injection, strictly under medical supervision; self-injection is contraindicated. Your healthcare provider will guide you on proper at-home injection technique. Dosage frequency is condition-dependent and determined by your physician to optimize treatment. Continue using this medication as prescribed. Common side effects include local injection site reactions (erythema, pruritus, irritation), nausea, and emesis. Rotate injection sites daily (e.g., abdomen) to minimize irritation. Report dizziness, syncope, abdominal pain, or persistent vomiting immediately. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and inform your doctor if breastfeeding. Complete medication history is crucial, as drug interactions may compromise efficacy or alter the drug's effects.
Uses of Eurelix 0.25mg Injection
Inability to conceive in women
Major Benefits of Eurelix 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Eurelix 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Eurelix 0.25mg Injection:
This medication will be administered by your physician or their qualified assistant. Self-medication is strictly prohibited.
How Eurelix 0.25mg Injection works:
During infertility treatment in women, premature egg release can occur, yielding oocytes unsuitable for conception. Eurelix 0.25mg Injection inhibits a natural hormone, thereby preventing premature ovarian follicle rupture.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Eurelix 0.25mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyUNSAFE
Administering Eurelix 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in animals and pregnant humans indicates considerable harm to the fetus.
Breast feedingUNSAFE
Administration of Eurelix 0.25mg Injection is contraindicated during lactation due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingSAFE
Administration of Eurelix 0.25mg Injection typically does not impair driving ability.
KidneyCAUTION
Exercise caution when administering Eurelix 0.25mg Injection to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Eurelix 0.25mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Eurelix 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eurelix 0.25mg Injection :
Omitting a scheduled Eurelix 0.25mg Injection requires contacting your physician.
Facts to Know About Eurelix 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Protein chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Active Class | GnRH receptor blockers |
3,018 People bought this recently